CD4 and metabolic dysfunction-associated steatotic liver disease: Hub Gene Verification and Diagnostic Ability Assessment Indicated That CD4, UGT2B7, and CYP3A4 may be the Potential Diagnostic Biomarkers of Non-alcoholic Fatty Liver Disease–Hepatocellular Carcinoma